These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17468644)

  • 81. Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: recommendations for college students). Committee on Infectious Diseases.
    Pediatrics; 2000 Dec; 106(6):1500-4. PubMed ID: 11099614
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006.
    Kinlin LM; Jamieson F; Brown EM; Brown S; Rawte P; Dolman S; Drews SJ; Fisman DN
    Vaccine; 2009 Mar; 27(11):1735-40. PubMed ID: 19186206
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prevention of meningococcal serogroup C disease by NeisVac-C.
    Borrow R; Findlow J
    Expert Rev Vaccines; 2009 Mar; 8(3):265-79. PubMed ID: 19249967
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Update on immunizations in children and adolescents.
    Ackerman LK
    Am Fam Physician; 2008 Jun; 77(11):1561-8. PubMed ID: 18581836
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Influenza vaccination coverage among children and adults - United States, 2008-09 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1091-5. PubMed ID: 19816396
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Vaccine update: new CDC recommendations from 2007.
    Campos-Outcalt D
    J Fam Pract; 2008 Mar; 57(3):181-4. PubMed ID: 18321455
    [No Abstract]   [Full Text] [Related]  

  • 88. Monitoring of adverse events during the 2003 mass vaccination campaign with a trivalent meningococcal A/C/W135 polysaccharide vaccine in Burkina Faso.
    Bentsi-Enchill AD; Zongo I; Khamassi S; Pless R; Thombiano R; Tiéndrebéogo S; Nelson CB; Duclos P
    Vaccine; 2007 Sep; 25 Suppl 1():A72-8. PubMed ID: 17544552
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Surveillance of vaccine breakthrough cases following MeNZB vaccination.
    McNicholas A; Galloway Y; Martin D; Sexton K; O'Hallahan J
    N Z Med J; 2008 Apr; 121(1272):38-46. PubMed ID: 18425153
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
    Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
    Velentgas P; Amato AA; Bohn RL; Chan KA; Cochrane T; Funch DP; Dashevsky I; Duddy AL; Gladowski P; Greenberg SA; Kramer JM; McMahill-Walraven C; Nakasato C; Spettell CM; Syat BL; Wahl PM; Walker AM; Zhang F; Brown JS; Platt R
    Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1350-8. PubMed ID: 22807266
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis.
    Stoehr GA; Luecken J; Zielen S; Eber SW; Borrow R; Rose MA
    Br J Surg; 2008 Apr; 95(4):466-71. PubMed ID: 18161897
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine.
    ;
    MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):258-60. PubMed ID: 18340332
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for use of hepatitis A vaccine in close contacts of newly arriving international adoptees.
    ;
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):1006-7. PubMed ID: 19763077
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Routine vaccines across the life span, 2007.
    Zimmerman RK; Middleton DB; Burns IT; Clover RD; Kimmel SR
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S18-37, C1-3. PubMed ID: 17270108
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Time of hope for the eventual elimination of meningococcal strains A, C, Y, and W-135 in the United States.
    Zimmerman RK
    Am Fam Physician; 2005 Nov; 72(10):1978, 1980. PubMed ID: 16342828
    [No Abstract]   [Full Text] [Related]  

  • 97. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
    Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
    Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Safety of a trivalent meningococcal ACW135 vaccine among young children in Ethiopia.
    Aseffa A; Bedru A; Yamuah L; Arga D; Worku A; Chandramohan D; Nelson CB; Engers HD
    Vaccine; 2007 Sep; 25 Suppl 1():A79-82. PubMed ID: 17548138
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Hepatitis a vaccination coverage among children aged 24-35 months - United States, 2006 and 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(25):689-94. PubMed ID: 19574951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.